Skip to main content
. 2017 Nov 22;61(12):e01292-17. doi: 10.1128/AAC.01292-17

TABLE 2.

Concentrations of radioactivity in tissues and fluids determined by QWBA at specified times after oral administration of [cyano-14C]isavuconazonium sulfate for up to 21 consecutive days in male albino ratsb

Matrix Concn of [cyano-14C]isavuconazonium sulfate (μg eq/g) at the indicated times after the last dose on:
Day 1
Day 7
Day 14
1 h 4 h 8 h 24 h 1 h 24 h 1 h 24 h
Adrenal cortex 10.1a 24.1a 19.0a 6.54a 20.9a 14.3a 23.1a 16.9a
Adrenal gland(s) 9.51a 22.7a 17.1a 5.83a 19.3a 12.4a 21.2a 14.0a
Adrenal medulla 8.04a 17.9a 10.8a 3.47a 11.7a 6.37a 19.2a 5.12a
Aorta 2.00 4.67 3.76 ND 2.75 1.51 4.53 2.35
Arterial wall ND 5.53 ND ND 1.88 ND 3.43 ND
Bile 101 198 109 27.3 472 27.7 157 ND
Blood 0.783 1.99 1.81 ND 1.70 1.34 3.04 1.41
Bone BLQ BLQ BLQ ND BLQ BLQ BLQ BLQ
Bone marrow 2.35 4.23 3.41 ND 1.90 0.979 4.03 BLQ
Brain cerebellum 1.55 3.28 2.11 ND 1.81 BLQ 2.74 BLQ
Brain cerebrum 1.51 3.36 2.02 ND 1.86 BLQ 2.72 BLQ
Brain medulla 1.60 3.52 2.22 ND 1.79 BLQ 2.93 BLQ
Brain olfactory lobe 1.46 2.93 1.70 ND 1.44 BLQ 2.46 BLQ
Bulbourethral gland 2.21 6.14 4.67 ND 3.08 0.933 4.60 1.27
Cecum BLQ 12.9 9.22 7.13 6.41 6.57 13.5 13.6
Cecum mucosa 4.12 15.8 13.7 7.42 16.6 11.4 18.2 10.9
Diaphragm 2.86 5.22 3.97 BLQ 3.52 0.920 5.01 1.27
Epididymis 1.00a 4.88 3.07 ND 1.57 0.819a 2.26a 0.925a
Esophagus 3.00 4.44 2.51 0.896 2.10 1.19 2.89 BLQ
Exorbital lacrimal gland 3.62 9.17 7.04 0.881 3.94 1.37 6.64 1.21
Eye lens BLQ BLQ BLQ ND BLQ BLQ BLQ BLQ
Eye uveal tract 1.21 2.40 1.31 ND 1.39 1.06 2.16 0.948
Eye(s) BLQ BLQ BLQ ND BLQ BLQ 0.787 BLQ
Fat (brown) 5.34 8.80 8.56 0.939 7.00 1.69 9.92 2.20
Fat (mesenteric) 0.802 23.4 21.0 1.80 2.96 2.21 1.17 2.67
Fat (reproductive) BLQ 16.0 15.5 2.27 3.76 3.66 2.03 3.73
Fat (white) 1.74 26.7 16.8 1.59 2.53 2.20 2.39 1.42
Harderian gland 3.63 12.6 9.14 1.03 4.55 1.73 6.58 1.38
Intra-orbital lacrimal gland 3.34 7.94 6.51 ND 3.38 1.39 6.77 1.33
Kidney cortex 4.67 10.4 6.96 ND 6.60 2.42 9.24 2.73
Kidney medulla 4.64 9.76 6.43 ND 6.10 2.43 9.31 2.33
Kidney(s) 4.65 10.2 6.80 1.42 6.46 2.43 9.29 2.58
Large intestine BLQ 3.25 4.05 1.91 3.49 1.90 4.00 1.46
Large intestine mucosa 2.55 4.80 2.88 1.92 3.21 4.06 5.32 2.31
Liver 35.8 38.3 31.5 7.53 40.1 15.6 58.8 18.4
Lung(s) 2.03 4.61 3.49 0.757 3.13 1.41 3.14 1.16
Lymph node(s) 1.22 3.57 3.02 ND 2.06 0.987 2.80 1.12
Lymph node(s), mandibular 1.35 3.61 2.78 ND 1.82 ND 2.96 ND
Muscle 1.32 3.64 2.43 BLQ 1.59 BLQ 1.84 BLQ
Myocardium 3.10 6.79 4.32 0.964 3.99 1.49 5.60 1.83
Nasal mucosa 1.36 6.08 3.64 0.895 1.98 1.19 3.17 1.76
Pancreas 3.99 8.09 5.77 0.749 4.20 1.05 6.34 1.17
Pineal body 1.84 5.31 3.93 ND 4.13 ND 4.47 ND
Pituitary gland 2.50 4.61 2.80 ND ND ND 4.85 ND
Preputial gland ND 8.32a 12.0a ND 4.00a 3.12a 4.52a 2.20a
Prostate gland 2.78 13.0 5.39 BLQ 3.24 1.10 3.23 1.17
Rectum mucosa 0.989 2.61 2.00 0.821 1.75 0.778 1.55 1.30
Salivary gland(s) 2.91 5.91 4.29 BLQ 3.56 0.868 5.03 0.941
Seminal vesicle(s) BLQ 3.32 1.62 BLQ 1.97 0.783 1.63 0.938
Skin (nonpigmented) 1.06 3.64 3.33 BLQ 1.87 0.988 2.16 1.01
Small intestine 1.74 4.50 12.9 3.65 9.95 3.07 10.0 2.57
Small intestine mucosa 3.15 14.6 21.7 7.81 16.7 7.26 21.9 9.43
Spinal cord 1.41 3.74 2.16 ND 1.80 ND 2.92 BLQ
Spleen 2.12 3.68 3.28 ND 2.47 1.00 4.02 1.11
Stomach 4.31 5.10 4.41 BLQ 4.74 1.56 5.93 1.11
Stomach mucosa 5.48 7.97 6.16 ND 6.27 ND 9.00 ND
Stomach wall 1.57 2.61 1.98 ND 3.19 ND 2.43 ND
Testis(es) 1.01 3.21 2.28 BLQ 1.50 0.882 2.26 1.00
Thymus 1.42 2.86 2.03 BLQ 1.53 BLQ 2.26 BLQ
Thyroid 2.15 5.39 3.76 ND 4.88 2.08 5.23 2.52
Tongue 2.43 5.70 3.59 BLQ 3.22 0.927 4.27 0.970
Tooth pulp 1.23 2.50 1.71 ND 1.67 1.07 3.07 0.884
Urinary bladder 5.39 9.97 3.69 3.77 4.79 1.71 2.67 12.8
Urine 8.85 119 102 9.75 16.6 16.4 58.0 20.4
a

Tissue appeared to be fat soaked.

b

[cyano-14C]isavuconazonium sulfate was administered at 30 mg/kg/day. BLQ, below the limit of quantitation (the lower limit of quantitation for day 1 was <0.742 μg eq [cyano-14C]isavuconazonium sulfate/g; the lower limit of quantitation for days 7 and 14 was <0.748 μg eq [cyano-14C]isavuconazonium sulfate/g); ND, not detectable (the borders of the sample were not discernible from the background or surrounding tissue); QWBA, quantitative whole-body autoradiography.